Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 4/20 | 1.00 |
| ▸ | LMNA | P02545 | 4/20 | 1.00 |
| ▸ | SLC6A2 | P23975 | 3/20 | 1.00 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 1.00 |
| ▸ | SQLE | Q14534 | 3/20 | 1.00 |
| ▸ | ADRA2A | P08913 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.62 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.62 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.62 |
| ▸ | HTR2A | P28223 | 2/20 | 0.62 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.62 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.62 |
| ▸ | HTT | P42858 | 2/20 | 0.62 |
| ▸ | DRD2 | P14416 | 1/20 | 0.62 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.62 |
| ▸ | CNR1 | P21554 | 1/20 | 0.62 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.62 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.62 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.62 |
| ▸ | EBP | Q15125 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Terbinafine SCHEMBL2028187 | 1.00 | CYP2D6 (1.00) | CYP2D6LMNASLC6A2SIGMAR1SQLE | |
| Terbinafine SCHEMBL2042785 | 1.00 | CYP2D6 (1.00) | CYP2D6LMNASLC6A2SIGMAR1SQLE | |
| Terbinafine SCHEMBL29353314 | 1.00 | CYP2D6 (1.00) | CYP2D6LMNASLC6A2SIGMAR1SQLE | |
| Terbinafine SCHEMBL31374681 | 1.00 | CYP2D6 (1.00) | CYP2D6LMNASLC6A2SIGMAR1SQLE | |
| Terbinafine SCHEMBL29627458 | 1.00 | CYP2D6 (1.00) | CYP2D6LMNASLC6A2SIGMAR1SQLE | |
| Terbinafine SCHEMBL36794 | 1.00 | CYP2D6 (1.00) | CYP2D6LMNASLC6A2SIGMAR1SQLE | |
| Terbinafine SCHEMBL5279646 | 1.00 | CYP2D6 (1.00) | CYP2D6LMNASLC6A2SIGMAR1SQLE | |
| Terbinafine SCHEMBL36795 | 0.99 | CYP2D6 (0.97) | CYP2D6LMNASLC6A2SIGMAR1SQLE | |
| Terbinafine SCHEMBL3597456 | 0.99 | CYP2D6 (0.97) | CYP2D6LMNASLC6A2SIGMAR1SQLE | |
| Terbinafine SCHEMBL29871278 | 0.99 | CYP2D6 (0.97) | CYP2D6LMNASLC6A2SIGMAR1SQLE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 32823 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026106917-A1 | EDIBLE TRANSMUCOSAL DRUG DELIVERY METHOD USING AN INTERMEDIATE CAPSULE AS A TEMPORARY VESSEL | BioPhysics Pharma, Inc. (US) | 2026-05-21 | — | — | WO | claimed |
| CN-122031290-A | Percutaneous permeation promoting system and preparation method and application thereof | 北京工商大学 | 2026-05-15 | — | — | CN | claimed |
| US-20260124224-A1 | USE OF COMBINED COMPOSITION IN PREPARING DRUG FOR RESISTING FUNGAL AND BACTERIAL INFECTIONS | NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY (CN) | 2026-05-07 | — | — | US | claimed |
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| EP-4731194-A1 | MATERIALS AND METHODS FOR MITIGATING THE PRESENCE OF NITROSAMINES IN PACKAGING USING AN ACTIVE AGENT | CSP Technologies, Inc. (US) | 2026-04-29 | — | — | EP | claimed |
| US-12605345-B2 | Transdermal drug delivery system | BioPhysics Pharma, Inc. (US) | 2026-04-21 | — | — | US | claimed |
| US-20260102363-A1 | TREATMENT METHOD AND ANTIFUNGAL COMPOSITION | MOBERG PHARMA AB (SE) | 2026-04-16 | — | — | US | claimed |
| US-20260102333-A1 | TOPICAL DELIVERY OF ANTIFUNGAL AGENTS FOR TREATING FUNGAL INFECTIONS | LYOTROPIC DELIVERY SYSTEMS Ltd (IL) | 2026-04-16 | — | — | US | claimed |
| US-20260102419-A1 | USE OF COMPOUNDS IN THE TREATMENT OF FUNGAL INFECTIONS | BASILEA PHARMACEUTICA INTERNATIONAL AG, ALLSCHWIL (CH) | 2026-04-16 | — | — | US | claimed |
| EP-3175865-B1 | FUNCTIONAL PARTICLES, PROCESS TO OBTAIN THEM, AND THEIR APPLICATIONS | SMART INOVATION LDA (PT) | 2026-04-15 | — | — | EP | claimed |
| US-5214046-A | Synergistic mixtures, inhibitors of sterol biosynthesis | HOFFMANN-LA ROCHE INC. (US) | 1993-05-25 | — | — | US | claimed |
| EP-0503988-A1 | Compositions to treat onychomycoses | SANDOZ LTD. (CH) | 1992-09-16 | — | — | EP | claimed |
| EP-0399858-B1 | CLEANSING COMPOSITION CONTAINING IN PARTICULAR NAFTIFINE AND/OR TERBINAFINE | L'OREAL (FR) | 1992-07-08 | — | — | EP | claimed |
| EP-0478456-A1 | Antifungal composition in dry aerosol form | SANDOZ LTD (CH) | 1992-04-01 | — | — | EP | claimed |
| EP-0310122-B1 | ANTIFUNGAL COMPOSITION | KAKEN PHARMACEUTICAL CO., LTD. (JP) | 1991-07-24 | — | — | EP | claimed |
| EP-0399858-A1 | Cleansing composition containing in particular naftifine and/or terbinafine | L'OREAL (FR) | 1990-11-28 | — | — | EP | claimed |
| US-4920112-A | SYNERGISTIC 25-AZASTEROL COMPOUND AND SQUALENE EPOXIDASE INHIBITOR | MERCK & CO., INC. (US) | 1990-04-24 | — | — | US | claimed |
| US-4894375-A | FUNGISTATS, KETOCONAZOLE | MERCK & CO., INC. (US) | 1990-01-16 | — | — | US | claimed |
| EP-0339708-A2 | Fungicidal compositions and method | MERCK & CO. INC. (US) | 1989-11-02 | — | — | EP | claimed |
| EP-0310122-A1 | Antifungal composition | KAKEN PHARMACEUTICAL CO., LTD. (JP) | 1989-04-05 | — | — | EP | claimed |